Niagen Bioscience, Inc. Common Stock NAGE Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Selling by Business | ||||||
| Analytical Reference Standards and Services segment | $284K-18.2% | $347K-11.0% | $390K-9.5% | $431K-8.9% | $473K-4.8% | |
| Consumer Products segment | $10.99M+2.0% | $10.77M+1.3% | $10.62M+5.2% | $10.1M+5.4% | $9.58M+3.2% | |
| Ingredients segment | $189K+31.3% | $144K+13.4% | $127K+58.8% | $80K-10.1% | $89K+123% | |
| Marketing by Business | ||||||
| Analytical Reference Standards and Services segment | $2K0.0% | $2K+100% | $1K— | $0-100% | $3K-25.0% | |
| Consumer Products segment | $12.46M+8.4% | $11.49M+13.5% | $10.13M+8.3% | $9.35M+5.0% | $8.9M+6.7% | |
| Ingredients segment | $173K+69.6% | $102K-50.2% | $205K+1.0% | $203K-2.4% | $208K+6.7% | |
| Advertising by Business | ||||||
| Analytical Reference Standards and Services segment | $0— | $0— | $0— | $0— | $0— | |
| Consumer Products segment | $12.97M+2.5% | $12.66M+2.6% | $12.34M+3.4% | $11.92M+2.9% | $11.59M+4.4% | |
| Ingredients segment | $0— | $0— | $0— | $0— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Niagen Bioscience, Inc. Common Stock break its business down?
- Niagen Bioscience, Inc. Common Stock (NAGE) reports net sales by business across 5 parts — Analytical Reference Standards and Services segment, Consumer Products segment, Corporate and other, Ingredients segment and Pharmaceuticals segment. Each is extracted from the segment footnotes and tracked over time.
- Where does Niagen Bioscience, Inc. Common Stock's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Niagen Bioscience, Inc. Common Stock's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
